Breast Examination Equipment (Global Market)

2024: Global Breast Examination Equipment Sales Increase to $4.75 Billion

At the end of 2024, the global market for equipment for examining dairy products amounted to $4.75 billion. This sector is showing a steady positive trend, as stated in a study by Maximize Market Research, the results of which Zdrav.Expert reviewed at the end of June 2025.

Analysts are considering areas such as screening mammography, diagnostic mammography, tomosynthesis of the breast, as well as MRI ULTRASONOGRAPHY the breast. The demand for such procedures is growing around the world amid an increase in the prevalence of breast malignancies. In 2022, it is estimated that World Health Organization (WHO) 2.3 million patients were diagnosed with this disease. - Breast cancer the most common cancer in the WHO European Region and the leading cause of cancer deaths among women.

It is noted that in many countries the diagnosis of most patients with breast cancer is made too late. Modern diagnostic equipment can help in solving the problem. Screening mammography is considered one of the most effective methods for detecting malignancies: this technology allows you to detect tumors of minimal size that cannot be felt with your hands. The study is painless and time-consuming. In turn, tomosynthesis makes it possible to carry out 3D imaging. MRI is an accurate and safe diagnostic method that allows you to detect changes in breast tissue at an early stage, as well as assess possible complications after the installation of implants. Ultrasound helps to analyze the structure and structure of tissues of the mammary glands, ducts, detect neoplasms, assess the state of regional lymph nodes.

The study says that an increase in sales of breast examination equipment is facilitated by an aging population. About half of women over 62 have breast cancer, according to the American Cancer Society. Technological advances have a positive impact on the industry: developers are constantly improving the characteristics of diagnostic equipment and expanding its functionality.

However, there are also restraining factors. One of them is the radiation load on the body during mammography. In addition, the purchase of modern equipment can create a significant financial burden for medical institutions - especially in developing countries.

In 2024, geographically, North America occupied the leading position in the global market for breast examination equipment with a share of 39.47% in monetary terms ($1.87 billion). Significant players on a global scale are named:

• Hologic;
• GE Healthcare;
• Siemens Healthineers;
• Koninklijke Philips N.V;
• Fujifilm Holdings;
• Canon;
• Aurora Healthcare;
• Allengers;
• Dilon Technologies;
• Planmed Oy;
• Delphinus Medical Tech;
• Micrima;
• CMR Naviscan;
• SuperSonic Imagine;
• Carestream Health;
• Aurora Imaging Technology;
• GE Medical Systems;
• Sonomed Escalon;
• Metaltronica;
• BMI Biomedical International;
• IMS Giotto;
• Agfa-Gevaert NV;
• CMR Surgical;
• Intrasense SA;
• Sectra AB.

According to analysts at Maximize Market Research, in the future, the CAGR in the market under consideration will be 6.79%. As a result, by 2032, sales of breast examination equipment could reach $8 billion.^[1]

2019: Breast Screening Equipment Market Size Reaches $3.54 Billion

In early January 2021, a report on the development of technologies for the medical visualization of the mammary glands appeared on the ResearchAndMarkets.com website. According to the data provided, the global market for relevant equipment in 2019 reached $3.54 billion.

An increase in the number of breast diseases in women, especially breast cancer, contributes to an increase in demand for these technologies. In addition, the growth of the global market can be attributed to initiatives by government and non-governmental organizations to raise public awareness of the benefits of early cancer detection. Technological progress and the development of advanced health infrastructure also contribute to the growth of the market.

Breast Screening Equipment Market Size Reaches $3.54 Billion in 2019

However, the high cost of imaging technologies, screening errors, strict rules and lengthy approval processes can hinder the development of the breast imaging technology market. On the other hand, increased investment in the health sector, campaigns to reduce breast cancer incidence and increased R&D in the medical sector are creating new opportunities for manufacturers.

The breast imaging technology market has been segmented by product type and geographic location. In terms of product type, the breast imaging technology market is divided into ionizing and non-ionizing imaging technologies. The ionizing segment is further subdivided into analog mammography, full-format digital mammography, three-dimensional breast tomosynthesis, positron emission tomography/computed tomography ( PET/CT ), molecular breast imaging/gamma breast imaging (MBI/BSGI), cone beam computed tomography, and positron emission mammography. The non-ionizing segment is subdivided into breast MRI, breast ultrasound, optical imaging, automated whole breast ultrasound, and breast thermography. Geographically, the market in the study is divided into North America, Europe, Asia-Pacific, and the rest of the world. Moreover, North America accounts for the lion's share of sales of breast screening equipment.^[2]

Notes